GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

June 28, 2020

Study Completion Date

June 28, 2020

Conditions
Ventilator Associated Pneumonia
Interventions
DRUG

Gram stain-guided antibiotic choice

The results of Gram staining of endotracheal aspirate are used to guide the selection of antibiotics.

DRUG

Guidelines-based antibiotics choice

Patients are administered the combination of an anti-pseudomonal agent and anti-MRSA agent according to IDSA/ATS guidelines

Trial Locations (12)

Unknown

Chukyo Hospital, Nagoya

Sapporo City General Hospital, Sapporo

Hitachi General Hospital, Hitachi

Ebina General Hospital, Ebina

University of the Ryukyus Hospital, Nishihara

Kansai Medical University Hospital, Hirakata

Kansai Medical University Medical Center, Moriguchi

Nagasaki University Hospital, Nagasaki

Osaka General Medical Center, Osaka

Saga University Hospital, Saga

Wakayama Medical University Hospital, Wakayama

668-8501

Tajima Emergency and Critical Care Medical Center, Toyooka

All Listed Sponsors
collaborator

Chukyo Hospital

UNKNOWN

collaborator

Ebina General Hospital

UNKNOWN

collaborator

Hitachi General Hospital

UNKNOWN

collaborator

Kansai Medical University

OTHER

collaborator

Kansai Medical University Medical Center

UNKNOWN

collaborator

Nagasaki University

OTHER

collaborator

Saga University

OTHER

collaborator

University of the Ryukyus

OTHER

collaborator

Wakayama Medical University

OTHER

collaborator

Tajima Emergency and Critical Care Medical Center

UNKNOWN

collaborator

Sapporo City General Hospital

UNKNOWN

lead

Osaka General Medical Center

OTHER

NCT03506113 - GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial | Biotech Hunter | Biotech Hunter